Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 9/8/2025CDE Seeks Comments on Draft Technical Guidelines for Chemically Synthe...
  • 9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...
  • 9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...
  • 9/8/2025CDE Issues Technical Guidelines for Clinical Pharmacology Research on ...
  • 9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...
  • 9/4/2025CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development
  • 8/29/2025​​​​​​​CDE Issues Draft Requirements for Module 2 Chemistry Doc...
  • 8/29/2025CDE Issues Technical Guideline for Non-Clinical Research of Vaccine Ad...
  • 8/29/2025CDE Invites Public Comment on 97th Batch of Reference Formulations for...
  • 8/29/2025CDE Solicits Comments on Draft Guideline for Post-Approval Change Mana...
  • 8/29/2025CDE Seeks Comment on ICH E6(R3) GCP Implementation Recommendations
  • 8/21/2025NMPA Lifts Import Suspension on Vasudha's Loratadine API
  • 8/21/2025China Proposes Conflict-of-Interest Declarations for Drug Clinical Tri...
  • 8/21/2025China Drafts Guidance on Single-Arm Trials to Support Oncology Drug Ap...
  • 8/14/2025CDE Seeks Public Input on Draft Guidelines for Bayesian Methods in Cli...
  • 8/14/2025CDE Issues New Technical Guidelines for Clinical Development of Osteoa...
  • 8/14/2025CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...
  • 8/14/2025CDE Seeks Public Input on Draft Guidelines for Rare Disease Drug Devel...
  • 8/6/2025CDE Releases Updated Roster of External Drug Review Experts
  • 8/6/2025CDE Solicits Comments on Guidelines for Developing Appropriate Drug Pa...
  • 8/6/2025CDE Seeks Public Comments on Revised Technical Guidelines for Recombin...
  • 8/5/2025China Seeks Public Feedback on New Internet Drug and Device Informatio...
  • 7/31/2025China Seeks Feedback on Draft Guidelines for Eosinophilic Esophagitis ...
  • 7/30/2025CDE Issues Technical Guidelines on Drug Exposure–Response Relationshi...
  • 7/30/2025CDE Releases New Guidelines on Impurity Limits for Fermentation or Sem...
  • 7/30/2025CDE Issues New Guidance on Clinical Pharmacology Research for Rare Dis...
  • 7/30/2025CDE Issues Technical Guidance on Model-Informed Drug Development for R...
  • 7/28/2025China Issues 2025 Edition of Controlled Drug Lists for Medical Narcoti...
  • 7/26/2025Ambroxol Hydrochloride Drops Reclassified as OTC Drug in China
  • 7/22/2025CDE Solicits Comments on Proposed Labeling Update for Pediatric Use of...
  • Page:3/7 Total number of articles:207: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group